Sort
51,593 grants matching “hepatitis”
Southern California Research Center for ALPD and Cirrhosis
$1,570,981Hidekazu Tsukamoto · University Of Southern California · P50 · FY2015 · AA
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$1,570,414Beth Israel Medical Ctr (New York) · U01 · FY2003 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,569,878Duke University · U01 · FY2002 · AI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence
$1,569,787T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Alcohol Center Of Research -- Nebraska (ACORN)
$1,569,501Carol A Casey · University Of Nebraska Medical Center · P50 · FY2023 · AA
Precursors of Suicide in Older Adults Transitioning from Prison to Community
$1,569,442Amy Lynn Byers · Northern California Institute/Res/Edu · RF1 · FY2018 · MH
A Multi-site Multi-Setting RCT of Integrated HIV Prevention and HCV Care for PWID
$1,569,047Lisa R Metsch · Columbia University Health Sciences · R01 · FY2020 · DA
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,568,875Thomas Leto · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,568,086Duke University · U01 · FY2003 · AI
Ancillary Studies of NAFLD and NASH in HIV infected Adults
$1,566,039Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2021 · DK
Toxic lipid intermediate accumulation and cobalamin depletion promote AHR-mediated hepatotoxicity and the progression of non-alcoholic fatty liver disease (NAFLD)-like pathologies
$1,565,100Timothy R Zacharewski · Michigan State University · R01 · FY2022 · ES
COPA, an Automated Medication Dispensing and Remote Management System for at Home Methadone Dispensing
$1,564,357John Timberlake · Berkshire Biomedical Corporation · R44 · FY2023 · DA
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
$1,564,216Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2024 · DA
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
$1,564,216Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2022 · DA
ADULT AIDS CLINICAL TRIALS UNIT
$1,564,044University Of Minnesota Twin Cities · U01 · FY2002 · AI
Molecular and Cellular Toxicology
$1,563,990Wayne State University · P30 · FY2004 · ES
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome
$1,562,834Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2022 · CA
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome
$1,562,554Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2025 · CA
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center
$1,562,234James A Tonascia · Johns Hopkins University · U24 · FY2023 · DK
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU
$1,562,076University Of Puerto Rico Med Sciences · U01 · FY2004 · AI
HEAL Data2Action Modeling and Economic Resource Center
$1,562,051Bruce R Schackman · Weill Medical Coll Of Cornell Univ · U24 · FY2025 · DA
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
$1,562,020Judith E Feinberg · University Of Cincinnati · U01 · FY2007 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$1,561,928Anna Wald · University Of Washington · UM1 · FY2022 · AI
Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection
$1,561,914Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U2C · FY2024 · TR
Boston-Area Research Training Program in Biomedical Informatics
$1,561,223Lucila Ohno-Machado · Harvard Medical School · T15 · FY2007 · LM